Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging

被引:8
|
作者
Bouattour, Mohamed [1 ]
Payance, Audrey [1 ]
Wassermann, Johanna [2 ]
机构
[1] Paris 7 Diderot, Beaujon Univ Hosp, AP HP, Dept Hepatol, 100 Blvd Gen Leclerc, F-92110 Clichy, France
[2] Paris 6 Pierre & Marie Curie, La Pitie Salpetriere Univ Hosp, AP HP, Dept Med Oncol, F-75013 Paris, France
关键词
Hepatocellular carcinoma; Antiangiogenic therapies; Sorafenib; Predictive biomarkers; Prognosis biomarkers; Functional imaging;
D O I
10.4254/wjh.v7.i20.2245
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Many years after therapeutic wilderness, sorafenib finally showed a clinical benefit in patients with advanced hepatocellular carcinoma. After the primary general enthusiasm worldwide, some disappointments emerged particularly since no new treatment could exceed or at least match sorafenib in this setting. Without these new drugs, research focused on optimizing care of patients treated with sorafenib. One challenging research approach deals with identifying prognostic and predictive biomarkers of sorafenib in this population. The task still seems difficult; however appropriate investigations could resolve this dilemma, as observed for some malignancies where other drugs were used.
引用
收藏
页码:2245 / 2263
页数:19
相关论文
共 50 条
  • [21] Contribution of biomarkers and imaging in the management of hepatocellular carcinoma
    Fartoux, Laetitia
    Decaens, Thomas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 : S21 - S30
  • [22] Imaging evaluation of hepatocellular carcinoma
    Kamel, IR
    Bluemke, DA
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2002, 13 (09) : S173 - S183
  • [23] Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
    Yuan, Z.
    Li, W. -T.
    Ye, X. -D.
    Zhu, H. -Y.
    Peng, W. -J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (07): : 599 - 605
  • [24] Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
    Z. Yuan
    W.-T. Li
    X.-D. Ye
    H.-Y. Zhu
    W.-J. Peng
    Clinical and Translational Oncology, 2014, 16 : 599 - 605
  • [25] Functional imaging techniques in hepatocellular carcinoma
    Goh, V.
    Sarker, D.
    Osmany, S.
    Cook, G. J. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) : 1070 - 1079
  • [26] Efficacy, Safety, and Biomarkers of Single- Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma
    Boige, Valerie
    Malka, David
    Bourredjem, Abderrahmane
    Dromain, Clarisse
    Baey, Charlotte
    Jacques, Nathalie
    Pignon, Jean-Pierre
    Vimond, Nadege
    Bouvet-Forteau, Nathalie
    De Baere, Thierry
    Ducreux, Michel
    Farace, Francoise
    ONCOLOGIST, 2012, 17 (08): : 1063 - 1072
  • [27] Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
    Zhu, Andrew X.
    Sahani, Dushyant V.
    Duda, Dan G.
    di Tomaso, Emmanuelle
    Ancukiewicz, Marek
    Catalano, Onofrio A.
    Sindhwani, Vivek
    Blaszkowsky, Lawrence S.
    Yoon, Sam S.
    Lahdenranta, Johanna
    Bhargava, Pankaj
    Meyerhardt, Jeffrey
    Clark, Jeffrey W.
    Kwak, Eunice L.
    Hezel, Aram F.
    Miksad, Rebecca
    Abrams, Thomas A.
    Enzinger, Peter C.
    Fuchs, Charles S.
    Ryan, David P.
    Jain, Rakesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3027 - 3035
  • [28] Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
    Shao, Y. -Y.
    Chen, B. -B.
    Ou, D. -L.
    Lin, Z. -Z.
    Hsu, C. -H.
    Wang, M. -J.
    Cheng, A. -L.
    Hsu, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (08) : 722 - 730
  • [29] Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
    Zhu, Andrew X.
    Ancukiewicz, Marek
    Supko, Jeffrey G.
    Sahani, Dushyant V.
    Blaszkowsky, Lawrence S.
    Meyerhardt, Jeffrey A.
    Abrams, Thomas A.
    McCleary, Nadine Jackson
    Bhargava, Pankaj
    Muzikansky, Alona
    Sheehan, Susan
    Regan, Eileen
    Vasudev, Eamala
    Knowles, Michelle
    Fuchs, Charles S.
    Ryan, David P.
    Jain, Rakesh K.
    Duda, Dan G.
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1557 - 1566
  • [30] Functional imaging techniques in hepatocellular carcinoma
    V. Goh
    D. Sarker
    S. Osmany
    G. J. R. Cook
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1070 - 1079